A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients

Clinical trial NCT02772822 · UNKNOWN

Trial details

NCT number: NCT02772822
Sponsor: Sinocelltech Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2016-06-01
Primary completion: 2019-06-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.